A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris

INTRODUCTION: Rituximab is slowly getting recognized as a promising steroid-sparing agent in the treatment of moderate to severe cases of pemphigus vulgaris (PV). We evaluated and compared the effectiveness, safety, and cost of therapy of rituximab versus dexamethasone cyclophosphamide pulse (DCP) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Sudip, Agarwal, Komal, Singh, Sonal, Halder, Deepika, Sinha, Sujata, De, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208287/
https://www.ncbi.nlm.nih.gov/pubmed/34188295
http://dx.doi.org/10.4103/ijd.IJD_306_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208287/
https://www.ncbi.nlm.nih.gov/pubmed/34188295
http://dx.doi.org/10.4103/ijd.IJD_306_20

Ejemplares similares